International Veterinary Information Service 

Expand Window  Reduce Window  Print  Close Window

spacer

In:  Clinical Neurology in Small Animals - Localization, Diagnosis and Treatment.  K. G. Braund (Ed.)

Publisher:  International Veterinary Information Service, Ithaca, New York, USA.

Storage Disorders
K. G. Braund

References

 
1.  Summers B, Cummings J, de Lahunta A. Veterinary Neuropathology. St Louis: Mosby, 1995; 208-350.  - Available from amazon.com -
 
2.  Patel V, Koppang N, Patel B, et al. P-phenylenediamine-mediated peroxidase deficiency in English setters with neuronal ceroid-lipofuscinosis. Lab Invest 1974; 30:366-368.
 
3.  Cummings JF, de Lahunta A, Riis RC, et al. Neuropathologic changes in a young adult Tibetan Terrier with subclinical neuronal ceroid-lipofuscinosis. Prog Vet Neurol 1990; 1:301-309.
 
4.  Riis RC, Cummings JF, Loew ER, et al. Tibetan terrier model of canine ceroid lipofuscinosis. Am J Med Genet 1992; 42:615-621.  - PubMed -
 
5.  Studdert VP, Mitten RW. Clinical features of ceroid lipofuscinosis in border collie dogs. Aust Vet J 1991; 68:137-140.  - PubMed -
 
6.  Rac R, Giesecke PR. Lysosomal storage disease in Chihuahuas. Aust Vet J 1975; 51:403-404.
 
7.  Vandevelde M, Fatzer R. Neuronal ceroid-lipofuscinosis in older dachshunds. Vet Pathol 1980; 17:686-692.  - PubMed -
 
8.  Hoover DM, Little PB, Cole WD. Neuronal ceroid-lipofuscinosis in a mature dog. Vet Pathol 1984; 21:359-361.
 
9.  Appleby EC, Longstaffe JA, Bell FR. Ceroid-lipofuscinosis in two Saluki dogs. J Comp Pathol 1982; 92:375-380.
 
10.  Hartley WJ, Canfield PJ, Donnelly TM. A suspected new canine storage disease. Acta Neuropathol 1982; 56:225-232.  - PubMed -
 
11.  Umemura T, Sato H, Goryo M, et al. Generalized lipofuscinosis in a dog. Nippon Juigaku Zasshi 1985; 47:673-677.
 
12.  Sisk DB, Levesque DC, Wood PA, et al. Clinical and pathologic features of ceroid lipofuscinosis in two Australian cattle dogs. J Am Vet Med Assoc 1990; 197:361-364.  - PubMed -
 
13.  Cho DY, Leipold HW, Rudolph R. Neuronal ceroidosis (ceroid-lipofuscinosis) in a Blue Heeler dog. Acta Neuropathol 1986; 69:161-164.  - PubMed -
 
14.  Bichsel P, Vandevelde M. A case of ceroid-lipofuscinosis in a Yugoslavian shepherd dog. Schweiz Arch Tierheilkd 1982; 124:413-418.
 
15.  Goebel HH, Bilzer T, Dahme E, et al. Morphological studies in canine (Dalmatian) neuronal ceroid- lipofuscinosis. Am J Med Genet 1988; Suppl 5:127-139.  - PubMed -
 
16.  Jolly RD, Hartley WJ, Jones BR, et al. Generalised ceroid-lipofuscinosis and brown bowel syndrome in Cocker spaniel dogs. N Z Vet J 1994; 42:236-239.
 
17.  Hanichen T, Puschner H. Generalized lipofuscinosis with neural complications in a dog. Vet Med Rev 1971; 1:27-39.
 
18.  Nimmo Wilkie JS, Hudson EB. Neuronal and generalized ceroid-lipofuscinosis in a cocker spaniel. Vet Pathol 1982; 19:623-628.
 
19.  Minatel L, Underwood SC, Carfagnini JC. Ceroid-lipofuscinosis in a Cocker Spaniel dog. Vet Pathol 2000; 37:488-490.  - PubMed -
 
20.  Cantile C, Buonaccorsi A, Pepe V, et al. Juvenile neuronal ceroid-lipofuscinosis (Batten's disease) in a Poodle dog. Prog Vet Neurol 1996; 7:82-87.
 
21.  Bjerkas E, Presthus J, Lium B. Ceroid lipofuscinosis in Gordon Setters. [Norwegian]. Norsk Vet 1990; 102:469-470.
 
22.  Nilsson SE, Wrigstad A. Electrophysiology in some animal and human hereditary diseases involving the retinal pigment epithelium. Eye 1997; 11:698-706.  - PubMed -
 
23.  Jolly RD, Sutton RH, Smith RI, et al. Ceroid-lipofuscinosis in miniature Schnauzer dogs. Aust Vet J 1997; 75:67.
 
24.  Green PD, Little PB. Neuronal ceroid-lipofuscin storage in Siamese cats. Can J Comp Med 1974; 38:207-212.
 
25.  Weissenbock H, Rossel C. Neuronal ceroid-lipofuscinosis in a domestic cat: clinical, morphological and immunohistochemical findings. J Comp Pathol 1997; 117:17-24.  - PubMed -
 
26.  Bildfell R, Matwichuk C, Mitchell S, et al. Neuronal ceroid-lipofuscinosis in a cat. Vet Pathol 1995; 32:485-488.  - PubMed -
 
27.  Nakayama H, Uchida K, Shouda T, et al. Systemic ceroid-lipofuscinosis in a Japanese domestic cat. J Vet Med Sci 1993; 55:829-831.  - PubMed -
 
28.  Sohar I, Sleat DE, Jadot M, et al. Biochemical characterization of a lysosomal protease deficient in classical late infantile neuronal ceroid lipofuscinosis (LINCL) and development of an enzyme-based assay for diagnosis and exclusion of LINCL in human specimens and animal models. J Neurochem 1999; 73:700-711.  - PubMed -
 
29.  Jolly RD. Comparative biology of the neuronal ceroid-lipofuscinoses (NCL): an overview. Am J Med Genet 1995; 57:307-311.  - PubMed -
 
30.  March PA, Wurzelmann S, Walkley SU. Morphological alterations in neocortical and cerebellar GABAergic neurons in a canine model of juvenile Batten disease. Am J Med Genet 1995; 57:204-212.  - PubMed -
 
31.  Siakotos AN, Blair PS, Savill JD, et al. Altered mitochondrial function in canine ceroid-lipofuscinosis. Neurochem Res 1998; 23:983-989.  - PubMed -
 
32.  Palmer DN, Tyynela J, van Mil HC, et al. Accumulation of sphingolipid activator proteins (SAPs) A and D in granular osmiophilic deposits in miniature Schnauzer dogs with ceroid- lipofuscinosis. J Inherit Metab Dis 1997; 20:74-84.  - PubMed -
 
33.  Palmer DN, Jolly RD, van Mil HC, et al. Different patterns of hydrophobic protein storage in different forms of neuronal ceroid lipofuscinosis (NCL, Batten disease). Neuropediatrics 1997; 28:45-48.  - PubMed -
 
34.  Gardiner RM. The molecular genetic basis of the neuronal ceroid lipofuscinoses. Neurol Sci 2000; 21(3):S15-S19.  - PubMed -
 
35.  Lingaas F, Aarskaug T, Sletten M, et al. Genetic markers linked to neuronal ceroid lipofuscinosis in English setter dogs. Anim Genet 1998; 29:371-376.  - PubMed -
 
36.  Shibuya H, Liu PC, Katz ML, et al. Coding sequence and exon/intron organization of the canine CLN3 (Batten disease) gene and its exclusion as the locus for ceroid-lipofuscinosis in English setter dogs. J Neurosci Res 1998; 52:268-275.  - PubMed -
 
37.  Koppang N. The English setter with ceroid-lipofuscinosis: a suitable model for the juvenile type of ceroid-lipofuscinosis in humans. Am J Med Genet Suppl 1988; 5:117-125.  - PubMed -
 
38.  Taylor RM, Farrow BR. Ceroid lipofuscinosis in the border collie dog: retinal lesions in an animal model of juvenile Batten disease. Am J Med Genet 1992; 42:622-627.  - PubMed -
 
39.  Koppang N. English setter model and juvenile ceroid-lipofuscinosis in man. Am J Med Genet 1992; 42:599-604.  - PubMed -
 
40.  Goebel HH, Dahme E. Retinal ultrastructure of neuronal ceroid-lipofuscinosis in the dalmatian dog. Acta Neuropathol 1985; 68:224-229.  - PubMed -
 
41.  Cummings JF, de Lahunta Ad. An adult case of canine neuronal ceroid-lipofuscinosis. Acta Neuropathol (Berl) 1977; 39:43-51. - PubMed -
 
42.  Armstrong D, Gadoth N, Harvey J. Sea-blue histiocytes in canine ceroid-lipofuscinosis (CCL). Blood Cells 1985; 11:151-155.  - PubMed -
 
43.  Armstrong D, Lombard C, Ellis A. Electrocardiographic and histologic abnormalities in canine ceroid- lipofuscinosis (CCL). J Mol Cell Cardiol 1986; 18:91-97.  - PubMed -
 
44.  Armstrong D, Gum G, Webb A, et al. Quantitative autofluorescence in the ovine and canine ocular fundus in ceroid-lipofuscinosis (Batten's disease). Vet Res Commun 1988; 12:453-456.  - PubMed -
 
45.  Franks JN, Dewey CW, Walker MA, et al. Computed tomographic findings of ceroid lipofuscinosis in a dog. J Am Anim Hosp Assoc 1999; 35:430-435.  - PubMed -
 
46.  Armstrong D, Quisling RG, Webb A, et al. Computed tomographic and nuclear magnetic resonance correlation of canine ceroid-lipofuscinosis with aging. Neurobiol Aging 1983; 4:297-303.  - PubMed -
 
47.  Kirchhoff A, Kobe C. Generalized ceroid-lipofuscinosis in a Cocker Spaniel dog. J Vet Med (Series A) 1994; 41:731-740.  - PubMed -
 
48.  Deeg HJ, Shulman HM, Albrechtsen D, et al. Batten's disease: failure of allogeneic bone marrow transplantation to arrest disease progression in a canine model. Clin Genet 1990; 37:264-270.  - PubMed -
 
49.  Abraham D, Blakemore WF, Dell A, et al. The enzymic defect and storage products in canine fucosidosis. Biochem J 1984; 222:25-33.  - PubMed -
 
50.  Smith MO, Wenger DA, Hill SL, et al. Fucosidosis in a family of American-bred English Springer Spaniels. J Am Vet Med Assoc 1996; 209:2088-2090.  - PubMed -
 
51.  Kelly WR, Clague AE, Barns RJ, et al. Canine alpha-L-fucosidosis: a storage disease of Springer Spaniels. Acta Neuropathol 1983; 60:9-13.  - PubMed -
 
52.  Littlewood JD, Herrtage ME, Palmer AC. Neuronal storage disease in English springer spaniels. Vet Rec 1983; 112:86-87.
 
53.  Keller RK, Armstrong D, Crum FC, et al. Dolichol and dolichyl phosphate levels in brain tissue from English Setters with ceroid lipofuscinosis. J Neurochem 1984; 42:1040-1047.  - PubMed -
 
54.  Taylor R, Farrow B, Healy P. Canine fucosidosis: clinical findings. J Small Anim Pract 1987; 28:291-300.
 
55.  Healy PJ, Farrow BR, Nicholas FW, et al. Canine fucosidosis: a biochemical and genetic investigation. Res Vet Sci 1984; 36:354-359.  - PubMed -
 
56.  Keller CB, Lamarre J. Inherited lysosomal storage disease in an English springer spaniel. J Am Vet Med Assoc 1992; 200:194-195.  - PubMed -
 
57.  Veeramachaneni DN, Smith MO, Ellinwood NM. Deficiency of fucosidase results in acrosomal dysgenesis and impaired sperm maturation. J Androl 1998; 19:444-449.  - PubMed -
 
58.  Taylor RM, Martin IC, Farrow BR. Reproductive abnormalities in canine fucosidosis. J Comp Pathol 1989; 100:369-380.  - PubMed -
 
59.  Barker C, Dell A, Rogers M, et al. Canine alpha-L-fucosidase in relation to the enzymic defect and storage products in canine fucosidosis. Biochem J 1988; 254:861-868.  - PubMed -
 
60.  Alroy J, Ucci AA, Warren CD. Human and canine fucosidosis: a comparative lectin histochemistry study. Acta Neuropathol 1985; 67:265-271.  - PubMed -
 
61.  Walkley SU. Pyramidal neurons with ectopic dendrites in storage diseases exhibit increased GM2 ganglioside immunoreactivity. Neuroscience 1995; 68:1027-1035.  - PubMed -
 
62.  Taylor RM, Farrow BR, Stewart GJ. Correction of enzyme deficiency by allogeneic bone marrow transplantation following total lymphoid irradiation in dogs with lysosomal storage disease (fucosidosis). Transplant Proc 1986; 18:326-329.
 
63.  Taylor RM, Farrow BR, Stewart GJ, et al. Enzyme replacement in nervous tissue after allogeneic bone-marrow transplantation for fucosidosis in dogs. Lancet 1986; 2:772-774.  - PubMed -
 
64.  Taylor RM, Farrow BR, Stewart GJ, et al. The clinical effects of lysosomal enzyme replacement by bone marrow transplantation after total lymphoid irradiation on neurologic disease in fucosidase deficient dogs. Transplant Proc 1988; 20:89-93.
 
65.  Taylor RM, Farrow BR, Stewart GJ, et al. Lysosomal enzyme replacement in neural tissue by allogeneic bone marrow transplantation following total lymphoid irradiation in canine fucosidosis. Transplant Proc 1987; 19:2730-2734.
 
66.  Taylor RM, Stewart GJ, Farrow BR. Comparison of the effect of total body and total lymphoid irradiation on bone marrow engraftment in MHC-matched dogs. Transplant Proc 1989; 21:3820-3821.
 
67.  Taylor RM, Stewart GJ, Farrow BR. Improvement in the neurologic signs and storage lesions of fucosidosis in dogs given marrow transplants at an early age. Transplant Proc 1989; 21:3818-3819.
 
68.  Taylor RM, Stewart GJ, Farrow BR, et al. Histological improvement and enzyme replacement in the brains of fucosidosis dogs after bone marrow engraftment. Transplant Proc 1989; 21:3074-3075.
 
69.  Taylor RM, Stewart GJ, Farrow BR, et al. The effect of bone marrow-derived cells on lysosomal enzyme activity in the brain after marrow engraftment. Transplant Proc 1989; 21:3822-3823.
 
70.  Stewart GJ, Taylor RM, Bell B, et al. Total lymphoid irradiation allows allogeneic bone marrow engraftment without GVHD in dogs but requires MHC matching. Transplant Proc 1989; 21:2962-2963.
 
71.  Occhiodoro T, Hopwood JJ, Morris CP, et al. Correction of alpha-L-fucosidase deficiency in fucosidosis fibroblasts by retroviral vector-mediated gene transfer. Hum Gene Ther 1992; 3:365-369.  - PubMed -
 
72.  Taylor RM, Farrow BR, Stewart GJ. Amelioration of clinical disease following bone marrow transplantation in fucosidase-deficient dogs. Am J Med Genet 1992; 42:628-632.  - PubMed -
 
73.  Skelly BJ, Sargan DR, Herrtage ME, et al. The molecular defect underlying canine fucosidosis. J Med Genet 1996; 33:284-288.  - PubMed -
 
74.  Skelly BJ, Sargan DR, Winchester BG, et al. Genomic screening for fucosidosis in English Springer Spaniels. Am J Vet Res 1999; 60:726-729.  - PubMed -
 
75.  Holmes NG, Acheson T, Ryder EJ, et al. A PCR-based diagnostic test for fucosidosis in English springer spaniels. Vet J 1998; 155:113-114.
 
76.  Knowles K, Alroy J, Castagnaro M, et al. Adult-onset lysosomal storage disease in a Schipperke dog: clinical, morphological and biochemical studies. Acta Neuropathol 1993; 86:306-312.  - PubMed -
 
77.  Blakemore WF. Neurolipidoses: examples of lysosomal storage diseases. Vet Clin North Am Small Anim Pract 1980; 10:81-90.
 
78.  Baker HJ, Mole JA, Lindsey JR, et al. Animal models of human ganglioside storage diseases. Fed Proc 1976; 35:1193-1201.
 
79.  Baker HJ, Reynolds GD, Walkley SU, et al. The gangliosidoses: comparative features and research applications. Vet Pathol 1979; 16:635-649.  - PubMed -
 
80.  Blakemore WF. GM-1 gangliosidosis in a cat. J Comp Pathol 1972; 82:179-185.
 
81.  Baker HJ, Lindsey JR. Animal model: feline GM1 gangliosidosis. Am J Pathol 1974; 74:649-652.
 
82.  Read DH, Harrington DD, Keenana TW, et al. Neuronal-visceral GM1 gangliosidosis in a dog with beta-galactosidase deficiency. Science 1976; 194:442-445.  - PubMed -
 
83.  Murray JA, Blakemore WF, Barnett KC. Ocular lesions in cats with GM1-gangliosidosis with visceral involvement. J Small Anim Pract 1977; 18:1-10.
 
84.  Alroy J, Orgad U, Ucci AA, et al. Neurovisceral and skeletal GM1-gangliosidosis in dogs with beta- galactosidase deficiency. Science 1985; 229:470-472.  - PubMed -
 
85.  Barker CG, Blakemore WF, Dell A, et al. GM1 gangliosidosis (type 1) in a cat. Biochem J 1986; 235:151-158.  - PubMed -
 
86.  Nowakowski RW, Thompson JN, Baker HJ. Diagnosis of feline GM1 gangliosidosis by enzyme assay of cultured conjunctival cells. Invest Ophthalmol Vis Sci 1988; 29:487-490.  - PubMed -
 
87.  Saunders GK, Wood PA, Myers RK, et al. GM1 gangliosidosis in Portuguese water dogs: pathologic and biochemical findings. Vet Pathol 1988; 25:265-269.  - PubMed -
 
88.  Shell LG, Potthoff AI, Carithers R, et al. Neuronal-visceral GM1 gangliosidosis in Portuguese water dogs. J Vet Intern Med 1989; 3:1-7.  - PubMed -
 
89.  Alroy J, Orgad U, DeGasperi R, et al. Canine GM1-gangliosidosis. A clinical, morphologic, histochemical, and biochemical comparison of two different models. Am J Pathol 1992; 140:675-689.  - PubMed -
 
90.  Muller G, Alldinger S, Moritz A, et al. GM1-gangliosidosis in Alaskan huskies: clinical and pathologic findings. Vet Pathol 2001; 38:281-290.  - PubMed -
 
91.  Yamato O, Ochiai K, Masuoka Y, et al. GM1 gangliosidosis in shiba dogs. Vet Rec 2000; 146:493-496.  - PubMed -
 
92.  Whitfield P, Johnson AW, Dunn KA, et al. GM1-gangliosidosis in a cross-bred dog confirmed by detection of GM1- ganglioside using electrospray ionisation-tandem mass spectrometry. Acta Neuropathol (Berl) 2000; 100:409-414.  - PubMed -
 
93.  De Maria R, Divari S, Bo S, et al. Beta-galactosidase deficiency in a Korat cat: a new form of feline GM1- gangliosidosis. Acta Neuropathol (Berl) 1998; 96:307-314.  - PubMed -
 
94.  Karbe E. G-M2 gangliosidosis and other neuronal lipodystrophies in amaurosis in the dog. A comparative histopathological, histochemical, electron microscope and biochemical study. Arch Exp Veterinarmed 1971; 25:1-48.
 
95.  Cork LC, Munnell JF, Lorenz MD. The pathology of feline GM2 gangliosidosis. Am J Pathol 1978; 90:723-734.  - PubMed -
 
96.  Eto Y, Autilio-Gambetti L, McGrath JT. Canine GM2-gangliosidosis: chemical and enzymatic features. Adv Exp Med Biol 1984; 174:431-440.  - PubMed -
 
97.  Neuwelt EA, Johnson WG, Blank NK, et al. Characterization of a new model of GM2-gangliosidosis (Sandhoff's disease) in Korat cats. J Clin Invest 1985; 76:482-490.  - PubMed -
 
98.  Cummings JF, Wood PA, Walkley SU, et al. GM2 gangliosidosis in a Japanese spaniel. Acta Neuropathol 1985; 67:247-253.  - PubMed -
 
99.  Eto Y, Ida H, Umezawa F, et al. Partial deficiency of beta-hexosaminidase activity in canine GM2- gangliosidosis. Tohoku J Exp Med 1987; 152:333-338.  - PubMed -
 
100.  Ishikawa Y, Li SC, Wood PA, et al. Biochemical basis of type AB GM2 gangliosidosis in a Japanese spaniel. J Neurochem 1987; 48:860-864.  - PubMed -
 
101.  Singer HS, Cork LC. Canine GM2 gangliosidosis: morphological and biochemical analysis. Vet Pathol 1989; 26:114-120.  - PubMed -
 
102.  Cork LC, Munnell JF, Lorenz MD, et al. GM2 ganglioside lysosomal storage disease in cats with beta- hexosaminidase deficiency. Science 1977; 196:1014-1017.  - PubMed -
 
103.  Alroy J, Knowles K, Schelling SH, et al. Retarded bone formation in GM1-gangliosidosis: a study of the infantile form and comparison with two canine models. Virchows Arch 1995; 426:141-148.
 
104.  Steiss JE, Baker HJ, Braund KG, et al. Profile of electrodiagnostic abnormalities in cats with GM1 gangliosidosis. Am J Vet Res 1997; 58:706-709.  - PubMed -
 
105.  Walkley SU. Further studies on ectopic dendrite growth and other geometrical distortions of neurons in feline GM1 gangliosidosis. Neuroscience 1987; 21:313-331.  - PubMed -
 
106.  Walkley SU, Pierok AL. Ferric ion-ferrocyanide staining in ganglioside storage disease establishes that meganeurites are of axon hillock origin and distinct from axonal spheroids. Brain Res 1986; 382:379-386.  - PubMed -
 
107.  Walkley SU, Baker HJ, Rattazzi MC, et al. Neuroaxonal dystrophy in neuronal storage disorders: evidence for major GABAergic neuron involvement. J Neurol Sci 1991; 104:1-8.  - PubMed -
 
108.  Kaye EM, Alroy J, Raghavan SS, et al. Dysmyelinogenesis in animal model of GM1 gangliosidosis. Pediatr Neurol 1992; 8:255-261.  - PubMed -
 
109.  Kroll RA, Pagel MA, Roman-Goldstein S, et al. White matter changes associated with feline GM2 gangliosidosis (Sandhoff disease): correlation of MR findings with pathologic and ultrastructural abnormalities. AJNR Am J Neuroradiol 1995; 16:1219-1226.  - PubMed -
 
110.  Farrell DF, Baker HJ, Herndon RM, et al. Feline GM 1 gangliosidosis: biochemical and ultrastructural comparisons with the disease in man. J Neuropathol Exp Neurol 1973; 32:1-18.
 
111.  Walkley SU, Wurzelmann S, Purpura DP. Ultrastructure of neurites and meganeurites of cortical pyramidal neurons in feline gangliosidosis as revealed by the combined Golgi-EM technique. Brain Res 1981; 211:393-398.  - PubMed -
 
112.  Cox NR, Ewald SJ, Morrison NE, et al. Thymic alterations in feline GM1 gangliosidosis. Vet Immunol Immunopathol 1998; 63:335-353.  - PubMed -
 
113.  Chavany C, Jendoubi M. Biology and potential strategies for the treatment of GM2 gangliosidoses. Mol Med Today 1998; 4:158-165.  - PubMed -
 
114.  O'Brien JS, Storb R, Raff RF, et al. Bone marrow transplantation in canine GM1 gangliosidosis. Clin Genet 1990; 38:274-280.  - PubMed -
 
115.  Lange AL, Brown JM, Maree CC. Biochemical studies on a lysosomal storage disease in Abyssinian cats. Onderstepoort J Vet Res 1983; 50:149-155.  - PubMed -
 
116.  Lange AL, Bland van den Berg P, Baker MK. A suspected lysosomal storage disease in Abyssinian cats. Part II: histopathological and ultrastructural aspects. J S Afr Vet Assoc 1977; 48:201-209.  - PubMed -
 
117.  Lange AL. Tissue culture studies on a suspected lysosomal storage disease in Abyssinian cats. Onderstepoort J Vet Res 1980; 47:121-127.  - PubMed -
 
118.  Bland van den Berg P, Baker MK, Lange AL. A suspected lysosomal storage disease in Abyssinian cats. Part I: genetic, clinical and clinical pathological aspects. J S Afr Vet Assoc 1977; 48:195-199.  - PubMed -
 
119.  Glew RH, Basu A, LaMarco KL, et al. Mammalian glucocerebrosidase: implications for Gaucher's disease. Lab Invest 1988; 58:5-25.
 
120.  Farrow BR, Hartley WJ, Pollard AC, et al. Gaucher disease in the dog. Prog Clin Biol Res 1982; 95:645-653.
 
121.  Hartley WJ, Farrow BR. Gaucher's disease. Comp Pathol Bull AFIP 1982; 14:2-4.
 
122.  Hartley WJ, Blakemore WF. Neurovisceral glucocerebroside storage (Gaucher's disease) in a dog. Vet Pathol 1973; 10:191-201.
 
123.  Van De Water NS, Jolly RD, Farrow BR. Canine Gaucher disease--the enzymic defect. Aust J Exp Biol Med Sci 1979; 57:551-554.  - PubMed -
 
124.  Kobayashi T, Goto I, Yamanaka T, et al. Infantile and fetal globoid cell leukodystrophy: analysis of galactosylceramide and galactosylsphingosine. Ann Neurol 1988; 24:517-522.  - PubMed -
 
125.  Kobayashi T, Shinnoh N, Goto I, et al. Hydrolysis of galactosylceramide is catalyzed by two genetically distinct acid beta-galactosidases. J Biol Chem 1985; 260:14982-14987.  - PubMed -
 
126.  Igisu H, Suzuki K. Progressive accumulation of toxic metabolite in a genetic leukodystrophy. Science 1984; 224:753-755.  - PubMed -
 
127.  Wenger DA, Victoria T, Rafi MA, et al. Globoid cell leukodystrophy in cairn and West Highland white terriers. J Hered 1999; 90:138-142.  - PubMed -
 
128.  Howell J, Palmer A. Globoid leukodystrophy in two dogs. J Small Anim Pract 1971; 12:633-642.
 
129.  McGrath J, Schutta H, Yaseen A, et al. A morphologic and biochemical study of canine globoid cell leukodystrophy. J Neuropathol Exp Neurol 1969; 28:191.
 
130.  Suzuki Y, Miyatake T, Fletcher TF, et al. Glycosphingolipid beta-galactosidases. 3. Canine form of globoid cell leukodystrophy; comparison with the human disease. J Biol Chem 1974; 249:2109-2112.
 
131.  Fletcher TF, Kurtz HJ, Low DG. Globoid cell leukodystrophy (Krabbe type) in the dog. J Am Vet Med Assoc 1966; 149:165-172.
 
132.  Fletcher TF, Kurtz HJ, Stadlan EM. Experimental Wallerian degeneration in peripheral nerves of dogs with globoid cell leukodystrophy. J Neuropathol Exp Neurol 1971; 30:593-602.
 
133.  Fletcher TF, Lee DG, Hammer RF. Ultrastructural features of globoid-cell leukodystrophy in the dog. Am J Vet Res 1971; 32:177-181.
 
134.  Fletcher TF, Kurtz HJ. Animal model: globoid cell leukodystrophy in the dog. Am J Pathol 1972; 66:375-378.
 
135.  Fletcher TF, Suzuki K, Martin FB. Galactocerebrosidase activity in canine globoid leukodystrophy. Neurology 1977; 27:758-766.  - PubMed -
 
136.  Fankhauser R, Luginbuhl H, Hartley W. Leukodystrophie von Typus Krabbe beim Hund. Schweiz Arch Tierheilkd 1965; 105:198-207.
 
137.  Johnson GR, Oliver JE, Jr., Selcer R. Globoid cell leukodystrophy in a Beagle. J Am Vet Med Assoc 1975; 167:380-384.  - PubMed -
 
138.  Zaki FA, Kay WJ. Globoid cell leukodystrophy in a miniature poodle. J Am Vet Med Assoc 1973; 163:248-250.
 
139.  Luttgen P, Braund K, Storts R. Globoid leukodystrophy in a bassett hound. J Small Anim Pract 1983; 24:153-160.
 
140.  Boysen BG, Tryphonas L, Harries NW. Globoid cell leukodystrophy in the bluetick hound dog. I. Clinical manifestations. Can Vet J 1974; 15:303-308.
 
141.  Selcer E, Selcer R. Globoid cell leukodystrophy in two west highland white terriers and one pomeranian. Compend Contin Educ Pract Vet 1984; 6:621-624.
 
142.  Johnson K. Globoid leukodystrophy in the cat. J Am Vet Med Assoc 1970; 157:2057-2064.
 
143.  McDonnell J, Carmichael K, McGraw R, et al. Preliminary characterization of globoid cell leukodystrophy in Irish Setters. J Vet Int Med 2000; 14:340.
 
144.  Vite C, Braund KG, McGowan J, et al. Clinical features of globoid leukodystrophy in the Cairn Terrier. In: Proceedings of the 14th Annu Symposium, ECVN 2000; 55-56.
 
145.  Roszel JF, Steinberg SA, McGrath JT. Periodic acid-Schiff-positive cells in cerebrospinal fluid of dogs with globoid cell leukodystrophy. Neurology 1972; 22:738-742.
 
146.  McGowan JC, Haskins M, Wenger DA, et al. Investigating demyelination in the brain in a canine model of globoid cell leukodystrophy (Krabbe disease) using magnetization transfer contrast: preliminary results. J Comput Assist Tomogr 2000; 24:316-321.  - PubMed -
 
147.  Cozzi F, Vite CH, Wenger DA, et al. MRI and electrophysiological abnormalities in a case of canine globoid cell leucodystrophy. J Small Anim Pract 1998; 39:401-405.  - PubMed -
 
148.  Jortner BS, Jonas AM. The neuropathology of globoid-cell leucodystrophy in the dog. A report of two cases. Acta Neuropathol (Berl) 1968; 10:171-182.
 
149.  Blakemore WF, Mitten RW, Palmer AC, et al. Value of a nerve biopsy in diagnosis of globoid cell leucodystrophy in the dog. Vet Rec 1974; 94:70-71.
 
150.  Vicini DS, Wheaton LG, Zachary JF, et al. Peripheral nerve biopsy for diagnosis of globoid cell leukodystrophy in a dog. J Am Vet Med Assoc 1988; 192:1087-1090.  - PubMed -
 
151.  Suzuki Y, Austin J, Armstrong D, et al. Studies in globoid leukodystrophy: enzymatic and lipid findings in the canine form. Exp Neurol 1970; 29:65-75.
 
152.  Victoria T, Rafi MA, Wenger DA. Cloning of the canine GALC cDNA and identification of the mutation causing globoid cell leukodystrophy in West Highland White and Cairn terriers. Genomics 1996; 33:457-462.  - PubMed -
 
153.  Bardens J, Bardens G, Bardens B. Clinical observation on a Von Gierke-like syndrome in puppies. Allied Vet 1961; 32:4-7.
 
154.  Walvoort HC. Glycogen storage diseases in animals and their potential value as models of human disease. J Inherit Metab Dis 1983; 6:3-16.  - PubMed -
 
155.  Bardens JW. Glycogen storage disease in puppies. Vet Med Small Anim Clin 1966; 61:1174-1176.
 
156.  Brix AE, Howerth EW, McConkie-Rosell A, et al. Glycogen storage disease type Ia in two littermate Maltese puppies. Vet Pathol 1995; 32:460-465.  - PubMed -
 
157.  Kishnani PS, Bao Y, Wu JY, et al. Isolation and nucleotide sequence of canine glucose-6-phosphatase mRNA: identification of mutation in puppies with glycogen storage disease type Ia. Biochem Mol Med 1997; 61:168-177.  - PubMed -
 
158.  Kishnani PS, Faulkner E, VanCamp S, et al. Canine model and genomic structural organization of glycogen storage disease type Ia (GSD Ia). Vet Pathol 2001; 38:83-91.  - PubMed -
 
159.  Walvoort HC, Nes JJv, Stokhof AA, et al. Canine glycogen storage disease type II: a clinical study of four affected Lapland dogs. J Am Anim Hosp Assoc 1984; 20:279-286.
 
160.  Walvoort HC, Dormans JA, van den Ingh TS. Comparative pathology of the canine model of glycogen storage disease type II (Pompe's disease). J Inherit Metab Dis 1985; 8:38-46.  - PubMed -
 
161.  Walvoort HC, Slee RG, Koster JF. Canine glycogen storage disease type II. A biochemical study of an acid alpha-glucosidase-deficient Lapland dog. Biochim Biophys Acta 1982; 715:63-69.  - PubMed -
 
162.  Walvoort HC, Koster JF, Reuser AJ. Heterozygote detection in a family of Lapland dogs with a recessively inherited metabolic disease: canine glycogen storage disease type II. Res Vet Sci 1985; 38:174-178.  - PubMed -
 
163.  Walvoort HC, Slee RG, Sluis KJ, et al. Biochemical genetics of the Lapland dog model of glycogen storage disease type II (acid alpha-glucosidase deficiency). Am J Med Genet 1984; 19:589-598.  - PubMed -
 
164.  Rafiquzzaman M, Svenkerud R, Strande A, et al. Glycogenosis in the dog. Acta Vet Scand 1976; 17:196-209.
 
165.  Ceh L, Hauge JG, Svenkerud R, et al. Glycogenosis type III in the dog. Acta Vet (Beogr) 1976; 17:210-222.
 
166.  Otani T, Mochizuki H. Glycogen storage disease (III ?) of dogs. Jikken Dobutsu 1977; 26:172-173.
 
167.  Svenkerud R, Hauge JG. Animal models of human disease: glycogenosis type III. Animal model: glycogenosis type III in the dog. Comparative Pathology Bulletin 1978; 10:2.
 
168.  Fyfe JC, Giger U, Van Winkle TJ, et al. Glycogen storage disease type IV: inherited deficiency of branching enzyme activity in cats. Pediatr Res 1992; 32:719-725.  - PubMed -
 
169.  Fyfe JC, Winkle TJv, Haskins ME, et al. Animal model of human disease. Glycogen storage disease type IV. Comparative Pathology Bulletin 1994; 26:3,6.
 
170.  Coates JR, Paxton R, Cox NR, et al. A case presentation and discussion of type IV glycogen storage disease in a Norwegian forest cat. Prog Vet Neurol 1996; 7:5-11.
 
171.  Van Winkle T, Fyfe J, Giger U, et al. Familial glycogen storage disease tyoe IV in Norwegian Forest cats; light microscopic and ultrastructural findings. In: Proceedings of the 41st Annu Meet Am Coll Vet Pathol 1990; 142.
 
172.  Giger U, Harvey JW. Hemolysis caused by phosphofructokinase deficiency in English springer spaniels: seven cases (1983-1986). J Am Vet Med Assoc 1987; 191:453-459.  - PubMed -
 
173.  Giger U, Harvey JW, Yamaguchi RA, et al. Inherited phosphofructokinase deficiency in dogs with hyperventilation- induced hemolysis: increased in vitro and in vivo alkaline fragility of erythrocytes. Blood 1985; 65:345-351.  - PubMed -
 
174.  Giger U, Kelly AM, Teno PS. Biochemical studies of canine muscle phosphofructokinase deficiency. Enzyme 1988; 40:25-29.  - PubMed -
 
175.  Giger U, Reilly MP, Asakura T, et al. Autosomal recessive inherited phosphofructokinase deficiency in English springer spaniel dogs. Anim Genet 1986; 17:15-23.  - PubMed -
 
176.  Giger U, Argov Z, Schnall M, et al. Metabolic myopathy in canine muscle-type phosphofructokinase deficiency. Muscle Nerve 1988; 11:1260-1265.  - PubMed -
 
177.  Skibild E, Dahlgaard K, Rajpurohit Y, et al. Haemolytic anaemia and exercise intolerance due to phosphofructokinase deficiency in related springer spaniels. J Small Anim Pract 2001; 42:298-300.  - PubMed -
 
178.  Harvey JW, Calderwood Mays MB, Gropp KE, et al. Polysaccharide storage myopathy in canine phosphofructokinase deficiency (type VII glycogen storage disease). Vet Pathol 1990; 27:1-8.  - PubMed -
 
179.  Smith BF, Stedman H, Rajpurohit Y, et al. Molecular basis of canine muscle type phosphofructokinase deficiency. J Biol Chem 1996; 271:20070-20074.  - PubMed -
 
180.  Giger U, Smith BF, Woods CB, et al. Inherited phosphofructokinase deficiency in an American cocker spaniel. J Am Vet Med Assoc 1992; 201:1569-1571.  - PubMed -
 
181.  Hegreberg G, Norby DFP. An inherited storage disease of cats. Fed Proc 1973; 32:821.
 
182.  Beccari T, Stinchi S, Orlacchio A. Lysosomal alpha-D-mannosidase. Biosci Rep 1999; 19:157-162.  - PubMed -
 
183.  DeGasperi R, al Daher S, Daniel PF, et al. The substrate specificity of bovine and feline lysosomal alpha-D- mannosidases in relation to alpha-mannosidosis. J Biol Chem 1991; 266:16556-16563.  - PubMed -
 
184.  Blakemore WF. A case of mannosidosis in the cat: clinical and histopathological findings. J Small Anim Pract 1986; 27:447-455.
 
185.  Burditt LJ, Chotai K, Hirani S, et al. Biochemical studies on a case of feline mannosidosis. Biochem J 1980; 189:467-473.  - PubMed -
 
186.  Cummings JF, Wood PA, de Lahunta A, et al. The clinical and pathologic heterogeneity of feline alpha-mannosidosis. J Vet Intern Med 1988; 2:163-170.  - PubMed -
 
187.  Jezyk PF, Haskins ME, Newman LR. Alpha-mannosidosis in a Persian cat. J Am Vet Med Assoc 1986; 189:1483-1485.  - PubMed -
 
188.  Maenhout T, Kint JA, Dacremont G, et al. Mannosidosis in a litter of Persian cats. Vet Rec 1988; 122:351-354.  - PubMed -
 
189.  Vandevelde M, Fankhauser R, Bichsel P, et al. Hereditary neurovisceral mannosidosis associated with alpha-mannosidase deficiency in a family of Persian cats. Acta Neuropathol 1982; 58:64-68.  - PubMed -
 
190.  Walkley SU, Blakemore WF, Purpura DP. Alterations in neuron morphology in feline mannosidosis. A Golgi study. Acta Neuropathol 1981; 53:75-79.  - PubMed -
 
191.  Walkley SU, Siegel DA. Ectopic dendritogenesis occurs on cortical pyramidal neurons in swainsonine-induced feline alpha-mannosidosis. Brain Res 1985; 352:143-148.  - PubMed -
 
192.  Abraham D, Daniel P, Dell A, et al. Structural analysis of the major urinary oligosaccharides in feline alpha-mannosidosis. Biochem J 1986; 233:899-904.  - PubMed -
 
193.  Raghavan S, Stuer G, Riviere L, et al. Characterization of alpha-mannosidase in feline mannosidosis. J Inherit Metab Dis 1988; 11:3-16.  - PubMed -
 
194.  Castagnaro M. Lectin histochemistry of the central nervous system in a case of feline alpha-mannosidosis. Res Vet Sci 1990; 49:375-377.  - PubMed -
 
195.  Alroy J, Warren CD, Raghavan SS, et al. Biochemical, ultrastructural and histochemical studies of cat placentae deficient in activity of lysosomal alpha-mannosidase. Placenta 1987; 8:545-553.  - PubMed -
 
196.  Berg T, Tollersrud OK, Walkley SU, et al. Purification of feline lysosomal alpha-mannosidase, determination of its cDNA sequence and identification of a mutation causing alpha- mannosidosis in Persian cats. Biochem J 1997; 328:863-870.  - PubMed -
 
197.  Sun H, Yang M, Haskins ME, et al. Retrovirus vector-mediated correction and cross-correction of lysosomal alpha-mannosidase deficiency in human and feline fibroblasts. Hum Gene Ther 1999; 10:1311-1319.  - PubMed -
 
198.  Vite C, McGowan J, Braund K, et al. Histopathology, electrodiagnostic testing, and magnetic resonance imaging show significant peripheral and central nervous system myelin abnormalities in the cat model of alpha-mannosidosis. J Neuropathol Exp Neurol 2001; 60:817-828.  - PubMed -
 
199.  Dyken P. Storage diseases: neuronal ceroid-lipofiscinoses, lipidoses, glycogenoses, and leukodystrophies In: Goetz C and Pappert E, eds. Textbook of clinical neurology. Philadelphia: WB Saunders, 1999; 560-582.  - Available from amazon.com -
 
200.  Haskins ME, Jezyk PF, Desnick RJ, et al. Mucopolysaccharidosis in a domestic short-haired cat: a disease distinct from that seen in the Siamese cat. J Am Vet Med Assoc 1979; 175:384-387.  - PubMed -
 
201.  Haskins ME, Aguirre GD, Jezyk PF, et al. The pathology of the feline model of mucopolysaccharidosis I. Am J Pathol 1983; 112:27-36.  - PubMed -
 
202.  Haskins ME, Jezyk PF, Desnick RJ, et al. Alpha-L-iduronidase deficiency in a cat: a model of mucopolysaccharidosis I. Pediatr Res 1979; 13:1294-1297.
 
203.  Haskins ME, McGrath JT. Meningiomas in young cats with mucopolysaccharidosis I. J Neuropathol Exp Neurol 1983; 42:664-670.  - PubMed -
 
204.  Kakkis ED, Schuchman E, He X, et al. Enzyme replacement therapy in feline mucopolysaccharidosis I. Mol Genet Metab 2001; 72:199-208.  - PubMed -
 
205.  He X, Li CM, Simonaro CM, et al. Identification and characterization of the molecular lesion causing mucopolysaccharidosis type I in cats. Mol Genet Metab 1999; 67:106-112.  - PubMed -
 
206.  Shull RM, Munger RJ, Spellacy E, et al. Canine alpha-L-iduronidase deficiency. A model of mucopolysaccharidosis I. Am J Pathol 1982; 109:244-248.
 
207.  Spellacy E, Shull RM, Constantopoulos G, et al. A canine model of human alpha-L-iduronidase deficiency. Proc Natl Acad Sci USA 1983; 80:6091-6095.  - PubMed -
 
208.  Shull RM, Helman RG, Spellacy E, et al. Morphologic and biochemical studies of canine mucopolysaccharidosis I. Am J Pathol 1984; 114:487-495.  - PubMed -
 
209.  Walkley SU, Haskins ME, Shull RM. Alterations in neuron morphology in mucopolysaccharidosis type I. A Golgi study. Acta Neuropathol 1988; 75:611-620.  - PubMed -
 
210.  Shull RM, Hastings NE. Fluorometric assay of alpha-L-iduronidase in serum for detection of affected and carrier animals in a canine model of mucopolysaccharidosis I. Clin Chem 1985; 31:826-827.  - PubMed -
 
211.  Shull RM, Breider MA, Constantopoulos GC. Long-term neurological effects of bone marrow transplantation in a canine lysosomal storage disease. Pediatr Res 1988; 24:347-352.  - PubMed -
 
212.  Breider MA, Shull RM, Constantopoulos G. Long-term effects of bone marrow transplantation in dogs with mucopolysaccharidosis I. Am J Pathol 1989; 134:677-692.  - PubMed -
 
213.  Lutzko C, Kruth S, Abrams-Ogg AC, et al. Genetically corrected autologous stem cells engraft, but host immune responses limit their utility in canine alpha-L-iduronidase deficiency. Blood 1999; 93:1895-1905.  - PubMed -
 
214.  Lutzko C, Omori F, Abrams-Ogg AC, et al. Gene therapy for canine alpha-L-iduronidase deficiency: in utero adoptive transfer of genetically corrected hematopoietic progenitors results in engraftment but not amelioration of disease. Hum Gene Ther 1999; 10:1521-1532.  - PubMed -
 
215.  Wilkerson MJ, Lewis DC, Marks SL, et al. Clinical and morphologic features of mucopolysaccharidosis type II in a dog: naturally occurring model of Hunter syndrome. Vet Pathol 1998; 35:230-233.  - PubMed -
 
216.  Fischer A, Carmichael KP, Munnell JF, et al. Sulfamidase deficiency in a family of Dachshunds: a canine model of mucopolysaccharidosis IIIA (Sanfilippo A). Pediatr Res 1998; 44:74-82.  - PubMed -
 
217.  Jolly RD, Ehrlich PC, Franklin RJ, et al. Histological diagnosis of mucopolysaccharidosis IIIA in a wire-haired dachshund. Vet Rec 2001; 148:564-567.  - PubMed -
 
218.  Aronovich EL, Carmichael KP, Morizono H, et al. Canine heparan sulfate sulfamidase and the molecular pathology underlying Sanfilippo syndrome type A in Dachshunds. Genomics 2000; 68:80-84.  - PubMed -
 
219.  Giger U, Wang P, Ellinwood NM, et al. Mucopolysaccharidosis type IIIB (Sanfilipo B syndrome) in Schipperke dogs. J Vet Intern Med 2001; 15:290.
 
220.  Langweiler M, Haskins M, Jezyk P. Mucopolysaccharidosis in a litter of cats. J Am Anim Hosp Assoc 1978; 14:748-751.
 
221.  Haskins ME, Jezyk PF, Patterson DF. Mucopolysaccharide storage disease in three families of cats with arylsulfatase B deficiency: leukocyte studies and carrier identification. Pediatr Res 1979; 13:1203-1210.
 
222.  Haskins ME, Bingel SA, Northington JW, et al. Spinal cord compression and hindlimb paresis in cats with mucopolysaccharidosis VI. J Am Vet Med Assoc 1983; 182:983-985.  - PubMed -
 
223.  Breton L, Guerin P, Morin M. A case of mucopolysaccharidosis VI in a cat. J Am Anim Hosp Assoc 1983; 19:891-896.
 
224.  Haskins ME, Aguirre GD, Jezyk PF, et al. The pathology of the feline model of mucopolysaccharidosis VI. Am J Pathol 1980; 101:657-674.  - PubMed -
 
225.  Yogalingam G, Litjens T, Bielicki J, et al. Feline mucopolysaccharidosis type VI. Characterization of recombinant N- acetylgalactosamine 4-sulfatase and identification of a mutation causing the disease. J Biol Chem 1996; 271:27259-27265.  - PubMed -
 
226.  Crawley AC, Yogalingam G, Muller VJ, et al. Two mutations within a feline mucopolysaccharidosis type VI colony cause three different clinical phenotypes. J Clin Invest 1998; 101:109-119.  - PubMed -
 
227.  Gasper PW, Thrall MA, Wenger DA, et al. Correction of feline arylsulphatase B deficiency (mucopolysaccharidosis VI) by bone marrow transplantation. Nature, UK 1984; 312:467-469.  - PubMed -
 
228.  Byers S, Nuttall JD, Crawley AC, et al. Effect of enzyme replacement therapy on bone formation in a feline model of mucopolysaccharidosis type VI. Bone 1997; 21:425-431.  - PubMed -
 
229.  Byers S, Crawley AC, Brumfield LK, et al. Enzyme replacement therapy in a feline model of MPS VI: modification of enzyme structure and dose frequency. Pediatr Res 2000; 47:743-749.  - PubMed -
 
230.  Bielicki J, Crawley AC, Davey RC, et al. Advantages of using same species enzyme for replacement therapy in a feline model of mucopolysaccharidosis type VI. J Biol Chem 1999; 274:36335-36343.  - PubMed -
 
231.  Neer TM, Dial SM, Pechman R, et al. Clinical vignette. Mucopolysaccharidosis VI in a miniature pinscher. J Vet Intern Med 1995; 9:429-433.
 
232.  Haskins ME, Desnick RJ, DiFerrante N, et al. Beta-glucuronidase deficiency in a dog: a model of human mucopolysaccharidosis VII. Pediatr Res 1984; 18:980-984.  - PubMed -
 
233.  Ray J, Bouvet A, DeSanto C, et al. Cloning of the canine beta-glucuronidase cDNA, mutation identification in canine MPS VII, and retroviral vector-mediated correction of MPS VII cells. Genomics 1998; 48:248-253.  - PubMed -
 
234.  Ray J, Scarpino V, Laing C, et al. Biochemical basis of the beta-glucuronidase gene defect causing canine mucopolysaccharidosis VII. J Hered 1999; 90:119-123.  - PubMed -
 
235.  Ray J, Haskins ME, Ray K. Molecular diagnostic tests for ascertainment of genotype at the mucopolysaccharidosis type VII locus in dogs. Am J Vet Res 1998; 59:1092-1095.  - PubMed -
 
236.  Sammarco C, Weil M, Just C, et al. Effects of bone marrow transplantation on the cardiovascular abnormalities in canine mucopolysaccharidosis VII. Bone Marrow Transplant 2000; 25:1289-1297.  - PubMed -
 
237.  Wolfe JH, Sands MS, Harel N, et al. Gene transfer of low levels of beta-glucuronidase corrects hepatic lysosomal storage in a large animal model of mucopolysaccharidosis VII. Mol Ther 2000; 2:552-561.  - PubMed -
 
238.  Fyfe JC, Kurzhals RL, Lassaline ME, et al. Molecular basis of feline beta-glucuronidase deficiency: an animal model of mucopolysaccharidosis VII. Genomics 1999; 58:121-128.  - PubMed -
 
239.  Bundza A, Lowden JA, Charlton KM. Niemann-Pick disease in a poodle dog. Vet Pathol 1979; 16:530-538.  - PubMed -
 
240.  Percy DH, Jortner BS. Feline lipidosis. Light and electron microscopic studies. Arch Pathol 1971; 92:136-144.
 
241.  Snyder SP, Kingston RS, Wenger DA. Niemann-Pick disease. Sphingomyelinosis of Siamese cats. Am J Pathol 1982; 108:252-254.
 
242.  Baker HJ, Wood PA, Wenger DA, et al. Sphingomyelin lipidosis in a cat. Vet Pathol 1987; 24:386-391.  - PubMed -
 
243.  Wenger DA, Sattler M, Kudoh T, et al. Niemann-Pick disease: a genetic model in Siamese cats. Science 1980; 208:1471-1473.  - PubMed -
 
244.  Johnson W. Lysosomal diseases and other storage diseases In: Rowland L ed. Merrit's textbook of neurology. 9th ed. Baltimore: Williams & Wilkins, 1995; 547-571.
 
245.  Yamagami T, Umeda M, Kamiya S, et al. Neurovisceral sphingomyelinosis in a Siamese cat. Acta Neuropathol 1989; 79:330-332.  - PubMed -
 
246.  Kamiya S, Yamagami T, Umeda M, et al. Lectin histochemistry of foamy cells in non-nervous tissues of feline sphingomyelinosis. J Comp Pathol 1991; 105:241-245.  - PubMed -
 
247.  Walkley SU, Baker HJ. Sphingomyelin lipidosis in a cat: Golgi studies. Acta Neuropathol 1984; 65:138-144.  - PubMed -
 
248.  Cuddon PA, Higgins RJ, Duncan ID, et al. Polyneuropathy in feline Niemann-Pick disease. Brain 1989; 112:1429-1443.  - PubMed -
 
249.  Munana KR, Luttgen PJ, Thrall MA, et al. Neurological manifestations of Niemann-Pick disease type C in cats. J Vet Intern Med 1994; 8:117-121.  - PubMed -
 
250.  Lowenthal AC, Cummings JF, Wenger DA, et al. Feline sphingolipidosis resembling Niemann-Pick disease type C. Acta Neuropathol 1990; 81:189-197.  - PubMed -
 
251.  Brown DE, Thrall MA, Walkley SU, et al. Feline Niemann-Pick disease type C. Am J Pathol 1994; 144:1412-1415.
 
252.  Somers KL, Wenger DA, Royals MA, et al. Complementation studies in human and feline Niemann-Pick type C disease. Mol Genet Metab 1999; 66:117-121.  - PubMed -
 
253.  Zervas M, Dobrenis K, Walkley SU. Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations. J Neuropathol Exp Neurol 2001; 60:49-64.  - PubMed -
 
254.  March PA, Thrall MA, Brown DE, et al. GABAergic neuroaxonal dystrophy and other cytopathological alterations in feline Niemann-Pick disease type C. Acta Neuropathol (Berl) 1997; 94:164-172.  - PubMed -
 
255.  Brown DE, Thrall MA, Walkley SU, et al. Metabolic abnormalities in feline Niemann-Pick type C heterozygotes. J Inherit Metab Dis 1996; 19:319-330.  - PubMed -
 
256.  Kuwamura M, Awakura T, Shimada A, et al. Type C Niemann-Pick disease in a boxer dog. Acta Neuropathol 1993; 85:345-348. - PubMed -
 
257.  Rotmistrovsky RA, Alcaraz A, Cummings JC, et al. GM2 gangliosidosis in a mixed-breed dog. Prog Vet Neurol 1991; 2:203-208.
 
258.  Midroni G, Bilbao JM. Biopsy diagnosis of peripheral neuropathy. Boston: Butterworth-Heinemann, 1995; 411-452. - Available from amazon.com -
 
259.  Fyfe JC, Hawkins MG, Henthorn P. Molecular characterization of feline glycogen storage disease type IV. Am J Hum Genet 1995; 57:A212.
 
260.  Fyfe JC, Kurzhals RL, Patterson DF, et al. Feline glycogenosis type IV is caused by a complex rearrangement deleting 6 kb of the branching enzyme gene and eliminating an exon. Am J Hum Genet 1997; 61:A251.
 
261.  Bosshard NU, Hubler M, Arnold S, et al. Spontaneous mucolipidosis in a cat: an animal model of human I-cell disease. Vet Pathol 1996; 33:1-13. - PubMed -
 
262.  Mazrier H, Knox VW, Holt E, et al. I-cell disease in cats. J Vet Intern Med 2002; 16:333.
 
263.  Ellinwood NM, Wang P, Skeen T, et al. Mucopolysaccharidosis IIIB (Sanfilipo syndrome type B) in Schipperke dogs: an adult onset progressive cerebellar neuropathy. In: Proceedings of ESVN, 15th Annu Sympo 2002.
 
264.  Foureman P, Stieger K, Ellinwood P, et al. Genetic mutation responsible for MPS VI in Miniature Pinschers. In: Proceedings of ESVN 15th Annu Sympo 2002.
 
265.  Marioni K, Steinberg SA, Ellinwood NM, et al. Somatosensory evoked potentials in MPS I affected cats. In: Proceedings of ESVN 15th Annu Sympo 2002.
 
266.  Beaty RM, Jackson M, Peterson D, et al. Delivery of glucose-6-phosphatase in a canine model for glycogen storage disease, type Ia, with adeno-associated virus (AAV) vectors. Gene Ther 2002;9:1015-1022. - PubMed -
 
267.  Jolly RD, Brown S, Das AM, et al. Mitochondrial dysfunction in the neuronal ceroid-lipofuscinoses (Batten disease). Neurochem Int 2002;40:565-571. - PubMed -
 
268.  Ponder KP, Melniczek JR, Xu L, et al. Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs. Proc Natl Acad Sci U S A 2002;99:13102-13107. - PubMed -
 
269.  Somers KL, Brown DE, Fulton R, et al. Effects of dietary cholesterol restriction in a feline model of Niemann-Pick type C disease. J Inherit Metab Dis 2001;24:427-436. - PubMed -
 
270.  Sigurdson CJ, Basaraba RJ, Mazzaferro EM, et al. Globoid cell-like leukodystrophy in a domestic longhaired cat. Vet Pathol 2002;39:494-496. - PubMed -
 
271.  Katz ML, Sanders DA, Sanders DN, et al. Assessment of plasma carnitine concentrations in relation to ceroid lipofuscinosis in Tibetan Terriers. Am J Vet Res 2002;63:890-895. - PubMed -
 
272.  Macri B, Marino F, Mazzullo G, et al. Mucopolysaccharidosis VI in a Siamese/short-haired European cat. J Vet Med A Physiol Pathol Clin Med 2002;49:438-442. - PubMed -
 
273.  Yogalingam G, Pollard T, Gliddon B, et al. Identification of a mutation causing mucopolysaccharidosis type IIIA in New Zealand Huntaway dogs. Genomics 2002;79:150-153. - PubMed -

 
 
footer